JLK-UIA

Bio & Pharma JLK gets OK from FDA for ICH diagnosis solution

South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, said on Monday it got 501K approval from the US Food and Drug Admin...

Bio & Pharma JLK gets FDA OK for prostate cancer diagnosis AI solution

South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, announced on Monday that it got approval from the US Food and Drug ...

Bio & Pharma JLK to supply medical AI solutions in Indonesia

South Korea’s JLK Inc., an AI-based stroke care platform maker, announced on Tuesday that it signed a business agreement with medical consulti...

Bio & Pharma Korea's JLK targets AI-based stroke care market in US

South Korea’s JLK Inc., an AI-based stroke care platform maker, will go all out to build its foothold in the US this year, aiming to lift its ...

Bio & Pharma JLK supplies AI stroke solutions to Philippines

JLK Inc., South Korea's stroke diagnosis specialist company, announced on Thursday it implemented two artificial intelligence (AI) stroke diagnostic...